Related Experiment Videos
Fungal left ventricular assist device endocarditis.
F Nurozler1, M Argenziano, M C Oz
1Department of Surgery, College of Physicians & Surgeons of Columbia University, New York, New York, USA.
The Annals of Thoracic Surgery
|March 10, 2001
Summary
Fungal infections, including left ventricular assist device (LVAD) endocarditis, are serious complications in patients with mechanical circulatory support. Early recognition and antifungal therapy are key to successful management, with device replacement sometimes necessary.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Devices
Background:
- Infection is a major threat for patients on long-term mechanical circulatory support.
- Fungal infections, particularly left ventricular assist device (LVAD) endocarditis, pose a significant risk.
Purpose of the Study:
- To analyze the incidence, management, and outcomes of fungal LVAD endocarditis.
Main Methods:
- Retrospective analysis of 165 patients who underwent TCI Heartmate LVAD implantation.
- Prospective data collection on infection-related endpoints.
- Focus on patients diagnosed with fungal LVAD endocarditis.
Main Results:
- 37 patients (22%) developed fungal infections; 5 (3%) had fungal LVAD endocarditis.
- Identifiable microbial portals of entry in all cases.
- Successful management in 4 out of 5 patients (80%).
Conclusions:
- Early recognition of nonspecific signs and prompt antifungal therapy are crucial for managing fungal LVAD endocarditis.
- Device removal/replacement may be necessary for device-specific manifestations or sepsis.
- Urgent transplantation or device replacement is indicated in specific clinical scenarios.